Intranasal Insulin for Prevention of Type 1 Diabetes
NCT00223613
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
240
Enrollment
OTHER
Sponsor class
Conditions
Type 1 Diabetes
Interventions
DRUG:
daily intranasal administration of insulin
Sponsor
University of Turku
Collaborators
[object Object]
[object Object]
[object Object]